NOT KNOWN FACTS ABOUT RO 5126766

Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely designed TPD strategies. During this review, we target both of those preclinical experiments and clinical trials to supply a comprehensive summary of the security and scientific performance of PROTACs and MGDs in hematologic malignancies i